Sign in
TerminatedNo phase

Prevalence and Characteristics of Intimate Partner Violence Against Individuals Seeking Hematological Consultations

Key facts

Who runs it
Centre Hospitalier Universitaire de Nīmes
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
138 people enrolled
Started
10 Sept 2024
Ended
11 Feb 2025
Type of study
Observational
Record updated
18 February 2025
Why it stopped
difficulty of inclusion, PI decision

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Currently in a relationship or has been in one in the last 12 months, regardless of the length of the relationship
  • Willing to complete the anonymous WAST self-questionnaire
  • able to read and understand French
  • Outpatient consultant at Nîmes University Hospital in one of the following departments:; Biological hematology consultation; Clinical hematology consultation; Vascular medicine consultation

Who cannot take part

  • Individuals under court protection, guardianship or curatorship
  • Individuals unable to read and understand French
  • Individuals who have already completed the WAST questionnaire during the study period
  • Individuals unable to get away from their partner during the consultation to complete the questionnaire in isolation

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Intimate violence against individuals, which is particularly marked among women, is one of the most widespread human rights violations in the world.

Read full original descriptionShow less

The Women Abuse Screening Tool (WAST) self-questionnaire is a screening tool validated in French.

Our preliminary data describing the association between intimate violence against women and the first attack of unexplained venous thromboembolic disease, show a significant frequency of positive responses to the WAST among women attending a biological hematology consultation at the CHU de Nîmes, for reasons of hemostasis disorders (8% out of the first 200 cases).

The study authors wish to establish the prevalence of this situation among patients presenting to the CHU de Nîmes for hematological exploration and management. They hypothesize that the prevalence of violence against individuals seen in Hematology consultations is higher among individuals with hemostasis pathologies (hemorrhagic and thrombotic pathologies) than those with cellular pathologies, and higher among women than men.

The group in the trial

  • Patients presenting at a biological hematology consultation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
18 February 2025